NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Intellia Therapeutics, Inc. (NASDAQ:NTLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/intellia-therapeutics-inc-lawsuit-submission-form?prid=129170&wire=1 or contact Joseph E. Levi, Esq.

image for news Intellia Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights – NTLA

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Edison International (NYSE:EIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edison-international-lawsuit-submission-form?prid=129169&wire=1 or contact Joseph E. Levi, Esq.

image for news Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Edison Internationa l(EIX)

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=129172&wire=1 or contact Joseph E. Levi, Esq.

image for news Investors in Neumora Therapeutics, Inc. Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - NMRA

Amazon's Cloud Miss May Be Even Worse Than You Think (but It Makes Sense) — Negative

AMZN   The Motley Fool — February 13, 2025

Anyone keeping a close eye on Amazon (AMZN -1.65%) these days certainly already knows the company's fourth-quarter cloud computing revenue fell just short of analyst estimates, marking the second consecutive quarterly miss for its cloud arm. That disappointment paired with lackluster guidance for the quarter now underway sent shares tumbling on Friday last week, just two days after they reached a record high.

image for news Amazon's Cloud Miss May Be Even Worse Than You Think (but It Makes Sense)

3 High-Yield Dividend Stocks I Can't Wait to Buy to Boost My Passive Income — Positive

ENB  MDT  VICI   The Motley Fool — February 13, 2025

I'm about to get a big cash infusion in my portfolio. Last year, private equity giant Blackstone agreed to buy one of my holdings, Retail Opportunity Investments Corp. , in an all-cash deal.

image for news 3 High-Yield Dividend Stocks I Can't Wait to Buy to Boost My Passive Income

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elastic N.V. ("Elastic" or "the Company") (NYSE: ESTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

image for news ESTC Investors Have Opportunity to Lead Elastic N.V. Securities Fraud Lawsuit with the Schall Law Firm

Pinterest Shares Soar on Strong Outlook. Is It Too Late to Buy the Stock? — Positive

PINS   The Motley Fool — February 13, 2025

Shares of Pinterest (PINS -1.19%) soared after the social media company reported strong results and issued an upbeat forecast. This flips the script for a stock that had come under pressure its prior two quarters due to weak guidance.

image for news Pinterest Shares Soar on Strong Outlook. Is It Too Late to Buy the Stock?

The chief executive of major Boeing customer Avolon said on Thursday he was really encouraged by progress being made by the U.S. manufacturer in stabilising production in the wake of a seven-week strike late last year.

image for news Major Boeing customer Avolon sees 'impressive' progress in production following strike

BEIJING , Feb. 13, 2025 /PRNewswire/ -- Gaotu Techedu Inc. ("Gaotu" or the "Company") (NYSE: GOTU), a technology-driven education company and online large-class tutoring service provider in China, today announced that it will report its financial results for the fourth quarter and fiscal year 2024 ended December 31, 2024, before U.S. markets open on Wednesday, February 26, 2025. Gaotu's management will hold an earnings conference call at 8:00 AM U.S. Eastern Time on Wednesday, February 26, 2025 (9:00 PM on the same day, Beijing/Hong Kong Time).

image for news Gaotu Techedu to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 26, 2025

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GSK plc ("GSK" or "the Company") (NYSE: GSK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 5, 2020 and August 14, 2022, inclusive (the "Class Period"), are encouraged to contact the firm before April 7, 2025.

image for news GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm

XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM). After the mainland of China, South Korea, Australia and Singapore, Taiwan market is the fifth APAC market in which XPOVIO® has been approved for public health insurance coverage.

image for news Antengene Announces XPOVIO® Approved for Public Health Insurance Coverage in Taiwan Market, Benefiting More Patients with R/R MM in the Region

GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy? — Positive

LLY   The Motley Fool — February 13, 2025

After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (LLY 0.92%) announced its full results and reiterated its earlier 2025 forecast. The company has been a big beneficiary of GLP-1 drugs that have seen soaring demand as they have been shown to greatly help with multiple health issues, including weight control.

image for news GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ: NTLA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 30, 2024 and January 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.

image for news NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. ("Neumora" or "the Company") (NASDAQ: NMRA) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents in connection with its initial public offering ("IPO") conducted on September 15, 2023, are encouraged to contact the firm before April 7, 2025.

image for news NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edison International ("Edison" or "the Company") (NYSE: EIX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 25, 2021 and February 6, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.

image for news EIX Investors Have Opportunity to Lead Edison International Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("Icon" or "the Company") (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before April 11, 2025.

image for news ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

Altria's Problems Go Deeper Than Just Falling Tobacco Sales — Negative

MO   The Motley Fool — February 13, 2025

Smoking rates have been declining significantly for decades. According to the American Lung Association, less than 12% of adults smoked in 2022, compared to nearly 43% in 1965.

image for news Altria's Problems Go Deeper Than Just Falling Tobacco Sales

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic Inc. ("Harmonic Inc.") (NASDAQ:HLIT) concerning possible violations of federal securities laws. Harmonic reported its third quarter financial results on February 10, 2025.

image for news Investors who lost money on Harmonic Inc. should contact Levi & Korsinsky about an ongoing investigation - HLIT

The German antitrust authority has notified Apple of concerns regarding the iPhone maker's app tracking tool, which could violate rules for large tech companies, the regulator said in a statement on Thursday.

image for news German cartel office warns Apple app tracking tool could violate rules

Meet the Glorious Growth Stock Billionaire Bill Ackman Is Buying Hand Over Fist — Positive

UBER   The Motley Fool — February 13, 2025

Bill Ackman is the founder and CEO of Pershing Square, a hedge fund with around $12.9 billion in assets under management. That includes billions of dollars invested in popular stocks like Alphabet, Nike, and Chipotle Mexican Grill.

image for news Meet the Glorious Growth Stock Billionaire Bill Ackman Is Buying Hand Over Fist